Syntekabio Clears Delisting Risk with Unqualified Audit Opinion 송영두 2026.03.20 오전 08:17 Syntekabio Suggests Potential of AI-Based Toxicity Prediction for Carcinogenic Risk Assessment 송영두 2026.03.23 오후 12:17 Syntekabio Showcases AI Drug Platform at Interbiz 2025 송영두 2025.07.07 오후 02:53 Syntekabio Expands Global Contracts, Boosts Growth with Next-Gen AI Platforms 송영두 2025.08.27 오후 05:34 ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse] 김새미 2025.11.12 오후 06:05 Syntekabio to Highlight AI Drug Discovery Tools at PEGS Boston 송영두 2025.05.09 오전 09:39 HLB Panagene Aims for 50% Global Sales in 3 Years 석지헌 2025.04.29 오후 04:34 Skin Booster Stocks Surge on Hunt for ‘Second Rejuran’ [K-bio Pulse] 김새미 2025.09.16 오전 08:00 Peptron, Oncocross Hit Kosdaq Upper Limits as Obesity, AI Drug Themes Rally 임정요 2025.04.14 오전 07:35 Syntekabio Partners with U.S. Proteco on Universal COVID Drug 송영두 2025.04.22 오전 07:31 더 보기 로딩중..
AIdrug
AIdrug
![ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/11/PS25111201284b.jpg)
![Skin Booster Stocks Surge on Hunt for ‘Second Rejuran’ [K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/09/PS25091600229b.jpg)
